(1S,2R,5R)-rel-3-azabicyclo[3.2.0]heptane-2-carboxylic acid

Catalog No. :
ACUORP272
CAS No. :
77859-21-3
Molecular Formula :
C7H11NO2
Molecular Weight :
141.17

IUPAC Name:(1S,2R,5R)-3-azabicyclo[3.2.0]heptane-2-carboxylic acid

(1S,2R,5R)-rel-3-azabicyclo[3.2.0]heptane-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$501.00Login to see priceIn stockInquiry
250mg98%$800.00Login to see priceIn stockInquiry
500mg98%$1334.00Login to see priceIn stockInquiry
1g98%$2000.00Login to see priceIn stockInquiry
5g98%$5999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,2R,5R)-rel-3-azabicyclo[3.2.0]heptane-2-carboxylic acid
IUPAC Name(1S,2R,5R)-3-azabicyclo[3.2.0]heptane-2-carboxylic acid
Molecular FormulaC7H11NO2
Molecular Weight141.17
SMILESO=C(O)[C@@H]1NC[C@H]2[C@@H]1CC2
InChI KeyWGVSZLKCAUSBGO-HCWXCVPCSA-N
Synonym77859-21-3 | (1S,2R,5R)-REL-3-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID | rel-(1S,2R,5R)-3-Azabicyclo[3.2.0]heptane-2-carboxylic acid | RAC-(1R,2S,5S)-3-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID | 2287246-57-3 | MFCD31697866 | AS-84601 | P18187 | EN300-
CAS No.77859-21-3
PubChem CID137945411

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUORP272 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUORP272 route product structure diagram
    ACUORP27277859-21-3 In Stock
Inquiry

2. ACUORP272 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUORP272 route product structure diagram
    ACUORP27277859-21-3 In Stock
Inquiry

Comments (0)